ArticleJournal of clinical medicine research2021

Anagliptin Monotherapy for Six Months in Patients With Type 2 Diabetes Mellitus and Hyper-Low-Density Lipoprotein Cholesterolemia Reduces Plasma Levels of Fasting Low-Density Lipoprotein Cholesterol and Lathosterol: A Single-Arm Intervention Trial.

Yuichi Ikegami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.